07:40 AM EST, 02/19/2025 (MT Newswires) -- Krystal Biotech ( KRYS ) reported Q4 net income Wednesday of $1.52 per diluted share, up from $0.30 a year earlier.

Analysts polled by FactSet expected $1.18.

Revenue for the quarter ended Dec. 31 was $91.1 million, compared with $42.1 million a year earlier.

Analysts surveyed by FactSet expected $90.6 million.

Shares of Krystal Biotech ( KRYS ) were down 4.3% in recent pre-market activity.